Related Experiment Video
Updated: Jan 7, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Chemotherapy-Induced Cardiotoxicity With Frontline BV-AVD for Hodgkin Lymphoma
Angelo Rizzolo1, Caroline Michel2, Nathalie A Johnson1
1Division of Hematology, Jewish General Hospital, Montreal, Quebec, Canada, jgh.ca.
Abstract:
Brentuximab vedotin (BV) with chemotherapy is a novel and an effective treatment for Hodgkin Lymphoma (HL) but is associated with increased rates of peripheral neuropathy and neutropenia. Since its increased use, novel adverse effects of the regimen have come to light, including unexpected toxicities. We report a case of BV-chemotherapy-induced cardiotoxicity, highlighting the need for vigilant monitoring and further research into the risk factors, mechanisms, and long-term safety profile of this therapy.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy V: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

